Antitumorigenic Effect of Hsp90 Inhibitor SNX-2112 on Tongue Squamous Cell Carcinoma is Enhanced by Low-Intensity Ultrasound

PURPOSE: The novel Hsp90 inhibitor SNX-2112 showed broad antitumor activity. However, it was still necessary to optimize the therapeutic dosage of SNX-2112 applied on tumors to obtain effective therapy with minimal dose to reduce toxicity. We investigated the role of low-intensity US in promoting an...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan, Chuanchuan, Zheng, Yuyan, Fan, Haidong, Sun, Haipeng, Huang, Shengxing, Li, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434630/
https://www.ncbi.nlm.nih.gov/pubmed/32884285
http://dx.doi.org/10.2147/OTT.S262174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434630/
https://www.ncbi.nlm.nih.gov/pubmed/32884285
http://dx.doi.org/10.2147/OTT.S262174

Ejemplares similares